Quest Diagnostics (DGX) Cash from Investing Activities (2009 - 2026)

Quest Diagnostics has disclosed Cash from Investing Activities across 18 years of filings, most recently posting -$152.0 million for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$152.0 million, down 32.17% year-over-year; the trailing twelve-month figure through Mar 2026 was -$668.0 million (up 72.73% YoY), and the FY2025 annual result was -$631.0 million, up 75.24% from the prior year.
• Cash from Investing Activities came in at -$152.0 million for Q1 2026 at Quest Diagnostics, up from -$191.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$82.0 million in Q2 2022 to a low of -$1.6 billion in Q3 2024.
• The 5-year median for Cash from Investing Activities is -$169.0 million (2022), against an average of -$290.3 million.
• Across the five-year window, Cash from Investing Activities slumped 1426.17% in 2024 and surged 87.69% in 2025, its largest moves.
• Quest Diagnostics' Cash from Investing Activities stood at -$174.0 million in 2022, then jumped by 34.48% to -$114.0 million in 2023, then sank by 340.35% to -$502.0 million in 2024, then surged by 61.95% to -$191.0 million in 2025, then grew by 20.42% to -$152.0 million in 2026.
• The last three Cash from Investing Activities figures came in at -$152.0 million (Q1 2026), -$191.0 million (Q4 2025), and -$201.0 million (Q3 2025), per Business Quant data.